Letter: Impact of Hepatitis B Core-Related Antigen on the Incidence of Hepatocellular Carcinoma in Patients Treated With Nucleos(t)ide Analogues-Further Clarifications Needed

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15254
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Impact of Hepatitis B Core-Related Antigen on the Incidence of Hepatocellular Carcinoma in Patients Treated With Nucleos(t)ide Analogues-Further Clarifications Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Which Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Should Receive Nucleos(t)ide Analogue Therapy? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Off-Treatment Efficacy of 3-Year Nucleos(t)ide Analogues in Chronic Hepatitis B Patients

Kaohsiung Journal of Medical Sciences
Medicine
2016English

Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study

Gastroenterology
HepatologyGastroenterology
2014English

Impact of Antiviral Therapy With Nucleos(t)ide Analog on Survival of Patients With HBV-related Small Hepatocellular Carcinomas

Cancer Management and Research
Oncology
2019English

Monitoring of Genotypic Resistance Profile in Chronic Hepatitis B Patients Receiving Nucleos(t)ide Analogues in Huzhou, China

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2016English

Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B

Current Hepatitis Reports
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy